Indicators
Indicators
Value
Direction
MACD(12,26,9)
1.259
Buy
RSI(14)
62.072
Neutral
STOCH(KDJ)(9,3,3)
55.981
Neutral
ATR(14)
15.771
Low Volatility
CCI(14)
-147.918
Sell
Williams %R
59.919
Sell
TRIX(12,20)
0.427
Sell
StochRSI(14)
47.679
Buy
Search
Chemed Corp
CHEAdd to Watchlist
424.040USD
+4.390+1.05%
Close 05/13, 16:00（ET）Quotes delayed by 15 min
5.63BMarket Cap
23.09P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Chemed Corp
Currency: USD Updated: 2026-05-12Key Insights
Chemed Corp's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 12 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 446.50.In the medium term, the stock price is expected to trend down.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Chemed Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
Chemed Corp Highlights
StrengthsRisks
Chemed Corporation is engaged in purchasing, operating, and divesting subsidiaries in diverse business activities. The Company's segment includes VITAS and the Roto-Rooter. The VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. It provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. The Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. The Roto-Rooter services are provided through a network of Company-owned branches, independent contractors and franchisees. The Company's water restoration services involve the remediation of water and humidity after a flood and are provided to both commercial and residential customers.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 8.97%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 8.97%.
Undervalued
The company’s latest PE is 22.85, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 13.97M shares, decreasing 12.42% quarter-over-quarter.
Held by HACAX
Star Investor HACAX holds 1.61K shares of this stock.
Analyst Rating
Based on
4
analysts
Buy
Current Rating
446.500
Target Price
+5.24%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Health
Currency: USD Updated: 2026-05-12The current financial score of Chemed Corp is 9.02, ranking 3 out of 75 in the Healthcare Providers & Services industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 657.51M, representing a year-over-year increase of 1.63%, while its net profit experienced a year-over-year increase of 7.60%.
Score
Financials
7.90
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
8.83
Operational Efficiency
8.66
Growth Potential
9.96
Shareholder Returns
9.77
Chemed Corp's Company Valuation
Currency: USD Updated: 2026-05-12The current valuation score of Chemed Corp is 5.07, ranking 71 out of 75 in the Healthcare Providers & Services industry. Its current P/E ratio is 22.85, which is 63.67% below the recent high of 37.40 and 12.45% above the recent low of 20.01.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 12/75
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2026-05-12The current earnings forecast score of Chemed Corp is 7.00, ranking 46 out of 75 in the Healthcare Providers & Services industry. The average price target is 576.00, with a high of 595.00 and a low of 550.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
4
analysts
Buy
Current Rating
446.500
Target Price
+5.95%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
68
Total
7
Median
8
Average
Company name
Ratings
Analysts
Chemed Corp
CHE
4
CVS Health Corp
CVS
29
HCA Healthcare Inc
HCA
27
Teladoc Health Inc
TDOC
27
Tenet Healthcare Corp
THC
24
Universal Health Services Inc
UHS
22
1
2
3
...
14
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2026-05-12The current price momentum score of Chemed Corp is 8.95, ranking 31 out of 75 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 458.51 and the support level at 375.90, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
423.040
Buy
MA10
424.037
Buy
MA20
410.620
Buy
MA50
397.125
Buy
MA100
420.802
Buy
MA200
431.129
Sell
Institutional Confidence
Currency: USD Updated: 2026-05-12The current institutional shareholding score of Chemed Corp is 10.00, ranking 1 out of 75 in the Healthcare Providers & Services industry. The latest institutional shareholding proportion is 105.26%, representing a quarter-over-quarter decrease of 5.94%. The largest institutional shareholder is Invesco, holding a total of 114.68K shares, representing 0.86% of shares outstanding, with 23.37% decrease in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Risk Assessment
Currency: USD Updated: 2026-05-12The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Providers & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Chemed Corp is 9.03, ranking 3 out of 75 in the Healthcare Providers & Services industry. The company's beta value is 0.54. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.
Score
Beta vs S&P 500 index
0.54
VaR
+2.14%
240-Day Maximum Drawdown
+35.88%
240-Day Volatility
+38.22%
Return
Best Daily Return
60 days
+9.96%
120 days
+9.96%
5 years
+9.96%
Worst Daily Return
60 days
-15.00%
120 days
-15.00%
5 years
-15.00%
Sharpe Ratio
60 days
-0.75
120 days
-0.06
5 years
+0.04
Risk Assessment
Maximum Drawdown
240 days
+35.88%
3 years
+43.35%
5 years
+43.35%
Return-to-Drawdown Ratio
240 days
-0.75
3 years
-0.17
5 years
-0.05
Skewness
240 days
-2.39
3 years
-1.94
5 years
-1.44
Volatility
Realised Volatility
240 days
+38.22%
5 years
+26.96%
Standardised True Range
240 days
+2.71%
5 years
+2.55%
Downside Risk-Adjusted Return
120 days
-6.21%
240 days
-6.21%
Maximum Daily Upside Volatility
60 days
+46.91%
Maximum Daily Downside Volatility
60 days
+42.45%
Liquidity
Average Turnover Rate
60 days
+1.86%
120 days
+1.44%
5 years
--
Turnover Deviation
20 days
+77.30%
60 days
+81.21%
120 days
+40.79%
Peer Comparison
Healthcare Providers & Services
Chemed Corp
CHE
8.11 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cigna Group
CI
8.63 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Encompass Health Corp
EHC
8.62 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Concentra Group Holdings Parent Inc
CON
8.42 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lifestance Health Group Inc
LFST
8.40 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Sotera Health Co
SHC
8.37 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
